Breaking News Instant updates and real-time market news.

INGN

Inogen

$137.39

3.57 (2.67%)

09:03
04/13/18
04/13
09:03
04/13/18
09:03

Inogen security incident exposed data of some rental customers

Inogen announced in a regulatory filing that it experienced a data security incident. Specifically, the company indicated that messages within an employee email account were accessed by unknown persons outside the company without authorization. "Some of the messages and files attached thereto may have contained personal information belonging to Inogen rental customers," it stated. The company, with the assistance of outside counsel, said it "immediately took steps to secure customer information and hired a leading forensics firm to investigate the incident and to bolster its security." The forensics firm hired to investigate the incident determined that an unauthorized individual may have gained access to personal information belonging to some Inogen rental customers including their name, address, telephone number, email address, date of birth, date of death, Medicare identification number, insurance policy information, and/or type of medical equipment provided. The impacted data did not include payment card information or medical records. The unauthorized access of the potentially impacted email account appears to have occurred between January 2, 2018 and March 14, 2018. Inogen is notifying approximately 30,000 current and former customers of this incident and will provide resources, including credit monitoring and an insurance reimbursement policy, to assist them. The company is also notifying the applicable regulatory authorities. In addition, the company determined that the unauthorized individual may have gained access to non-public financial information. Inogen added, "The Company takes the security of information belonging to its customers very seriously and has taken steps to prevent a similar incident from occurring in the future. Specifically, the Company has increased the security of Inogen systems by requiring all email users to change their passwords following the incident and sooner than they would have otherwise been required to. The Company has also implemented multi-factor authentication for remote email access and has taken additional steps to further limit access to its systems and other preventative measures, including but not limited to enhanced training and use of electronic tools. The Company has insurance coverage in place for certain potential liabilities and costs relating to the incident, but this insurance is limited in amount, subject to a deductible, and may not be adequate to protect against all costs arising from this incident."

  • 19

    Apr

  • 06

    Jun

  • 07

    Jun

  • 12

    Jun

INGN Inogen
$137.39

3.57 (2.67%)

12/22/17
NEED
12/22/17
NO CHANGE
Target $32
NEED
Strong Buy
Boston Scientific, Inogen favorite 2018 picks in med tech at Needham
Needham analyst Mike Matson expects 2018 med tech fundamentals to remain stable in 2018 and thinks the medical sector is entering 2018 on "solid footing." Matson's favorite stock and favorite large-cap pick for 2018 is Boston Scientific (BSX), and favorite small/mid-cap pick is Inogent (INGN), both of which are Strong Buy rated. The analyst thinks Boston Scientific has a strong product cycle that should allow it to outpace peers and views 2018 consensus estimates as conservative. For Inogen, Matson sees further upside from the rapid adoption of POCs by home medial equipment companies, direct-to-consumer revenue growth, and very conservative guidance.
02/20/18
PIPR
02/20/18
UPGRADE
PIPR
Overweight
Inogen upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst JP McKim upgraded Inogen (INGN) to Overweight and raised his price target for the shares to $137 from $96. The analyst also keeps an Overweight rating on Tactile Systems (TCMD) with a $36 price target. McKim, who just took over coverage of both names, believes the companies "have disruptive business models in going direct to consumer" in an "ever-changing healthcare environment." Benefiting Inogen, the analyst thinks oxygen tanks will go away in 10 years.
02/28/18
NEED
02/28/18
NO CHANGE
Target $150
NEED
Strong Buy
Inogen price target raised to $150 from $125 at Needham
Needham analyst Mike Matson raised his price target on Inogen to $150 after the company's Q4 earnings beat and raised FY18 outlook. Matson notes that the revenue upside came from both domestic B2B and direct to consumer offerings, which both grew by over 35%, though margins declined on higher SG&A expenses. Matson keeps his Strong Buy rating, forecasting sales force expansion and Medicare reimbursement to produce even faster DTC growth this year.
04/02/18
PIPR
04/02/18
NO CHANGE
PIPR
Overweight
Piper remains buyer of Inogen with Mobi a no-show at conference
Piper Jaffray analyst JP McKim says that while we did not attend Med Trade conference in Vegas late last week, he heard from some who did attend that there was no sign of ResMed's (RMD) Mobi at the conference and reps said there is no official launch date on the calendar. He believes that ResMed either chose not to showcase Mobi at Med Trade or there is a delay in the launch. McKim believes that ultimately Inogen (INGN) "will continue to have the best technology and innovation engine." He adds that less competition is always a good thing. The analyst remains a buyer of Inogen.

TODAY'S FREE FLY STORIES

OSUR

OraSure

$17.32

0.01 (0.06%)

06:46
07/16/18
07/16
06:46
07/16/18
06:46
Downgrade
OraSure rating change  »

OraSure downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 08

    Aug

NEP

NextEra Energy Partners

$45.91

-0.51 (-1.10%)

06:46
07/16/18
07/16
06:46
07/16/18
06:46
Downgrade
NextEra Energy Partners rating change  »

NextEra Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

HYG

iShares iBoxx $ High Yield Corporate Bond

$85.63

0.005 (0.01%)

06:46
07/16/18
07/16
06:46
07/16/18
06:46
Technical Analysis
iShares iBoxx $ High Yield Corporate Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$28.54

-0.24 (-0.83%)

06:46
07/16/18
07/16
06:46
07/16/18
06:46
Earnings
Bank of America reports Q2 EPS 63c, consensus 57c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$115.76

0.16 (0.14%)

06:46
07/16/18
07/16
06:46
07/16/18
06:46
Technical Analysis
iShares iBoxx $ Investment Grade Corporate Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNLF

Samsung

$0.00

(0.00%)

, AAPL

Apple

$191.32

0.19 (0.10%)

06:45
07/16/18
07/16
06:45
07/16/18
06:45
Periodicals
Samsung patent could rival Apple Watch technology, Business Insider reports »

After applying for the…

SSNLF

Samsung

$0.00

(0.00%)

AAPL

Apple

$191.32

0.19 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

TLT

iShares 20+ Year Treasury Bond Fund

$122.74

0.33 (0.27%)

06:45
07/16/18
07/16
06:45
07/16/18
06:45
Technical Analysis
iShares 20+ Year Treasury Bond Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$106.33

-0.47 (-0.44%)

06:45
07/16/18
07/16
06:45
07/16/18
06:45
Hot Stocks
JPMorgan reports June net credit losses 2.39% vs. 2.56% last month »

Reports June 30-plus day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

SLV

iShares Silver Trust

$14.88

-0.13 (-0.87%)

06:44
07/16/18
07/16
06:44
07/16/18
06:44
Technical Analysis
iShares Silver Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$350.81

4.79 (1.38%)

, EADSY

Airbus

$0.00

(0.00%)

06:43
07/16/18
07/16
06:43
07/16/18
06:43
Periodicals
Boeing, Airbus struggling to deliver new jets they promised, WSJ reports »

Boeing (BA) and Airbus…

BA

Boeing

$350.81

4.79 (1.38%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

USLV

VelocityShares 3x Long Silver ETN

$8.52

-0.25 (-2.85%)

06:43
07/16/18
07/16
06:43
07/16/18
06:43
Technical Analysis
VelocityShares 3x Long Silver ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYF

Synchrony

$32.44

-0.51 (-1.55%)

06:43
07/16/18
07/16
06:43
07/16/18
06:43
Hot Stocks
Synchrony reports June charge off rate 4.73% vs. 5.26% last month »

Reports June 30-plus day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 08

    Aug

IYR

DJ US Real Estate Index Fund

$81.37

-0.19 (-0.23%)

06:42
07/16/18
07/16
06:42
07/16/18
06:42
Technical Analysis
DJ US Real Estate Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBB

iShares Nasdaq Biotechnology Index

$118.36

0.2 (0.17%)

06:42
07/16/18
07/16
06:42
07/16/18
06:42
Technical Analysis
iShares Nasdaq Biotechnology Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LABD

Daily S&P Biotech Bear 3x Shares

$21.90

0.15 (0.69%)

06:41
07/16/18
07/16
06:41
07/16/18
06:41
Technical Analysis
Daily S&P Biotech Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAR

Saratoga Investment

$24.63

-0.08 (-0.32%)

06:41
07/16/18
07/16
06:41
07/16/18
06:41
Upgrade
Saratoga Investment rating change  »

Saratoga Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

EWH

MSCI Hong Kong Index

$24.46

0.07 (0.29%)

06:41
07/16/18
07/16
06:41
07/16/18
06:41
Technical Analysis
MSCI Hong Kong Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INNT

Innovate Biopharmaceuticals

$23.72

0.12 (0.51%)

06:40
07/16/18
07/16
06:40
07/16/18
06:40
Conference/Events
Innovate Biopharmaceuticals management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

EWG

iShares MSCI Germany

$30.64

0.095 (0.31%)

06:40
07/16/18
07/16
06:40
07/16/18
06:40
Technical Analysis
iShares MSCI Germany: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPX

GP Strategies

$19.00

0.4 (2.15%)

06:40
07/16/18
07/16
06:40
07/16/18
06:40
Conference/Events
GP Strategies management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 19

    Jul

IJR

iShares Core S&P Small Cap ETF

$85.89

-0.07 (-0.08%)

06:39
07/16/18
07/16
06:39
07/16/18
06:39
Technical Analysis
iShares Core S&P Small Cap ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBH

Sally Beauty

$16.37

0.01 (0.06%)

06:39
07/16/18
07/16
06:39
07/16/18
06:39
Downgrade
Sally Beauty rating change  »

Sally Beauty downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

GLYC

GlycoMimetics

$17.12

0.32 (1.90%)

06:39
07/16/18
07/16
06:39
07/16/18
06:39
Conference/Events
GlycoMimetics management to meet with SunTrust »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

EEM

MSCI Emerging Markets Index

$43.86

0.06 (0.14%)

06:39
07/16/18
07/16
06:39
07/16/18
06:39
Technical Analysis
MSCI Emerging Markets Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAT

Waters

$198.07

-0.5 (-0.25%)

06:39
07/16/18
07/16
06:39
07/16/18
06:39
Downgrade
Waters rating change  »

Waters downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.